article thumbnail

A history of blood cancer treatment

pharmaphorum

The first well-documented case of multiple myeloma was reported in 1844 by renowned British surgeon Samuel Solly. Crucially, he observed a connection between certain tumours and inflammation, noting that neoplastic tissues were often covered with leukocytes of the immune system. 1844 – First reported case of multiple myeloma.

article thumbnail

Eric Halioua, President & CEO at PDC*line Pharma Shares Insights on the Results from P-I/II Trial with PDC*lung01

PharmaShots

We are very pleased to demonstrate that our innovative immunotherapy platform can induce a strong immune response in humans. We reported at ESMO-IO the analysis of immune response of the first 3 cohorts of patients. Anti-PD-1 antibodies have recently become standard first-line treatments for melanoma and NSCLC. 2015; Zhu et al.,